JoVE Logo
Faculty Resource Center

Sign In

Enhancement of Apoptotic and Autophagic Induction by a Novel Synthetic C-1 Analogue of 7-deoxypancratistatin in Human Breast Adenocarcinoma and Neuroblastoma Cells with Tamoxifen

DOI :

10.3791/3586-v

May 30th, 2012

May 30th, 2012

18,558 Views

1Department of Chemistry and Biochemistry, University of Windsor, 2Chemistry Department and Centre for Biotechnology, Brock University

We have synthesized a novel analogue of pancratistatin with comparable anti-cancer activity as native pancratistatin; interestingly, combinatory treatment with tamoxifen yielded a drastic enhancement in apoptotic and autophagic induction by mitochondrial targeting with minimal effect on noncancerous fibroblasts. Thus, JCTH-4 in combination with tamoxifen could provide a safe anti-cancer therapy.

Tags

Apoptotic Induction

-- Views

Related Videos

article

Isolation, Characterization and Comparative Differentiation of Human Dental Pulp Stem Cells Derived from Permanent Teeth by Using Two Different Methods

article

Cell Death Associated with Abnormal Mitosis Observed by Confocal Imaging in Live Cancer Cells

article

Initiation of Metastatic Breast Carcinoma by Targeting of the Ductal Epithelium with Adenovirus-Cre: A Novel Transgenic Mouse Model of Breast Cancer

article

Profiling of Estrogen-regulated MicroRNAs in Breast Cancer Cells

article

Utilization of the Soft Agar Colony Formation Assay to Identify Inhibitors of Tumorigenicity in Breast Cancer Cells

article

Studying Pancreatic Cancer Stem Cell Characteristics for Developing New Treatment Strategies

article

Systems Biology of Metabolic Regulation by Estrogen Receptor Signaling in Breast Cancer

article

Induction of Accelerated Atherosclerosis in Mice: The "Wire-Injury" Model

article

A Novel Clinical Grade Isolation Method for Human Kidney Perivascular Stromal Cells

article

In Vitro and In Vivo Detection of Mitophagy in Human Cells, C. Elegans, and Mice

JoVE Logo

Privacy

Terms of Use

Policies

Research

Education

ABOUT JoVE

Copyright © 2024 MyJoVE Corporation. All rights reserved